+653.1%
ASTS vs THC
+418.9%
+234.2%
-77.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -15.2% | -2.0% | -13.2% | -14.9% |
| 7D | -29.9% | +5.9% | -35.8% | -30.6% |
| 30D | -52.2% | +10.8% | -63.0% | -53.0% |
| 3M | -55.8% | +9.4% | -65.3% | -56.6% |
| 6M | -52.7% | +53.3% | -106.0% | -57.3% |
| YTD | -58.4% | +44.2% | -102.6% | -61.9% |
| 1Y | -57.1% | +37.3% | -94.4% | -60.2% |
| All | +653.1% | +418.9% | +234.2% | +503.8% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling